MIRM

Mirum Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Peetz ChristopherDirector, Officer: CHIEF EXECUTIVE OFFICER
$1.6M16.6k shares
SellJun 1, 2026
$95.34
--
Peetz ChristopherDirector, Officer: CHIEF EXECUTIVE OFFICER
$666k6.9k shares
SellJun 1, 2026
$96.15
--
Ramasastry SairaDirector
$398k4k shares
SellJun 1, 2026
$100.00
--
Peetz ChristopherDirector, Officer: CHIEF EXECUTIVE OFFICER
$246k2.6k shares
SellJun 1, 2026
$94.64
--
Peetz ChristopherDirector, Officer: CHIEF EXECUTIVE OFFICER
$192k2k shares
SellJun 1, 2026
$97.56
--
Peetz ChristopherDirector, Officer: CHIEF EXECUTIVE OFFICER
$100k1k shares
SellJun 1, 2026
$98.20
--

News

zacks.comMIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)zacks.comJun 17zacks.comMIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)zacks.comJun 16zacks.comMIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Reviewzacks.comJun 15gurufocus.comMirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressivagurufocus.comJun 14businesswire.comMirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressivabusinesswire.comJun 14